CytoDyn’s leronlimab shows improvement in CSP patient with Covid-19,

The antibody has so far been studied in 11 clinical trials involving over 1,200 individuals. It has also met primary endpoints in a pivotal Phase III trial of …, The antibody has so far been studied in 11 clinical trials involving over 1,200 individuals. It has also met primary endpoints in a pivotal Phase III trial of …, Read More

Scroll to Top